Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111292073> ?p ?o ?g. }
- W2111292073 endingPage "4513" @default.
- W2111292073 startingPage "4509" @default.
- W2111292073 abstract "The aim of this study wsa to evaluate the additive effect of valproic acid (VPA) to γδ T-cell cytotoxicity against bladder cancer cells. Materials and Methods: Human bladder cancer cell lines TCCSUP and 253J were treated with VPA and mRNA expression of natural killer group 2D (NKG2D) ligands was determined. The antitumour effect of expanded γδ T-cells against zoledronic acid (ZOL) and VPA pre-treated cancer cells was subsequently determined. Results: VPA increased mRNA expression of NKG2D ligands on both cancer cell types. A blocking study revealed that 253J cells were recognised through NKG2D, while TCCSUP cells were mainly recognised through γδ T-cell receptor. VPA pre- treatment increased sensitivity to cytolysis by γδ T-cells for both cancer cell types, whereas ZOL pre-treatment was only effective against TCCSUP. Conclusion: Induction of NKG2D ligands by VPA increased the susceptibility of cancer cells that are recognised by NKG2D to cytolysis by γδ T-cells. Superficial bladder carcinomas represent 70% of all bladder carcinomas and are managed with transurethral surgical treatment followed by intravesical instillation of chemotherapeutic agents or Bacillus Calmette-Guerin (BCG) treatment (1). BCG, which exerts antitumour effects through the local immune response, is considered the most effective agent, particularly in carcinoma in situ (2). Other immunotherapeutic approaches, including vaccine therapy," @default.
- W2111292073 created "2016-06-24" @default.
- W2111292073 creator A5013831161 @default.
- W2111292073 creator A5025196347 @default.
- W2111292073 creator A5057490410 @default.
- W2111292073 creator A5086284506 @default.
- W2111292073 creator A5088294789 @default.
- W2111292073 creator A5089184223 @default.
- W2111292073 creator A5091577352 @default.
- W2111292073 date "2010-11-01" @default.
- W2111292073 modified "2023-10-02" @default.
- W2111292073 title "The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands." @default.
- W2111292073 cites W1950937581 @default.
- W2111292073 cites W1972814015 @default.
- W2111292073 cites W1978029914 @default.
- W2111292073 cites W1978277750 @default.
- W2111292073 cites W1992699637 @default.
- W2111292073 cites W2014075623 @default.
- W2111292073 cites W2019822903 @default.
- W2111292073 cites W2024667955 @default.
- W2111292073 cites W2036188114 @default.
- W2111292073 cites W2043545955 @default.
- W2111292073 cites W2092868870 @default.
- W2111292073 cites W2113195478 @default.
- W2111292073 cites W2115393755 @default.
- W2111292073 cites W2115814074 @default.
- W2111292073 cites W2125252957 @default.
- W2111292073 cites W2125994015 @default.
- W2111292073 cites W2139558439 @default.
- W2111292073 cites W2140457510 @default.
- W2111292073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21115900" @default.
- W2111292073 hasPublicationYear "2010" @default.
- W2111292073 type Work @default.
- W2111292073 sameAs 2111292073 @default.
- W2111292073 citedByCount "10" @default.
- W2111292073 countsByYear W21112920732013 @default.
- W2111292073 countsByYear W21112920732016 @default.
- W2111292073 countsByYear W21112920732017 @default.
- W2111292073 countsByYear W21112920732018 @default.
- W2111292073 countsByYear W21112920732021 @default.
- W2111292073 countsByYear W21112920732022 @default.
- W2111292073 countsByYear W21112920732023 @default.
- W2111292073 crossrefType "journal-article" @default.
- W2111292073 hasAuthorship W2111292073A5013831161 @default.
- W2111292073 hasAuthorship W2111292073A5025196347 @default.
- W2111292073 hasAuthorship W2111292073A5057490410 @default.
- W2111292073 hasAuthorship W2111292073A5086284506 @default.
- W2111292073 hasAuthorship W2111292073A5088294789 @default.
- W2111292073 hasAuthorship W2111292073A5089184223 @default.
- W2111292073 hasAuthorship W2111292073A5091577352 @default.
- W2111292073 hasConcept C109316439 @default.
- W2111292073 hasConcept C121608353 @default.
- W2111292073 hasConcept C126322002 @default.
- W2111292073 hasConcept C1491633281 @default.
- W2111292073 hasConcept C185592680 @default.
- W2111292073 hasConcept C202751555 @default.
- W2111292073 hasConcept C203014093 @default.
- W2111292073 hasConcept C2777701055 @default.
- W2111292073 hasConcept C2778102761 @default.
- W2111292073 hasConcept C2778867473 @default.
- W2111292073 hasConcept C2780352672 @default.
- W2111292073 hasConcept C502942594 @default.
- W2111292073 hasConcept C54355233 @default.
- W2111292073 hasConcept C55493867 @default.
- W2111292073 hasConcept C71924100 @default.
- W2111292073 hasConcept C73588182 @default.
- W2111292073 hasConcept C81885089 @default.
- W2111292073 hasConcept C86803240 @default.
- W2111292073 hasConcept C8891405 @default.
- W2111292073 hasConcept C96232424 @default.
- W2111292073 hasConcept C98274493 @default.
- W2111292073 hasConceptScore W2111292073C109316439 @default.
- W2111292073 hasConceptScore W2111292073C121608353 @default.
- W2111292073 hasConceptScore W2111292073C126322002 @default.
- W2111292073 hasConceptScore W2111292073C1491633281 @default.
- W2111292073 hasConceptScore W2111292073C185592680 @default.
- W2111292073 hasConceptScore W2111292073C202751555 @default.
- W2111292073 hasConceptScore W2111292073C203014093 @default.
- W2111292073 hasConceptScore W2111292073C2777701055 @default.
- W2111292073 hasConceptScore W2111292073C2778102761 @default.
- W2111292073 hasConceptScore W2111292073C2778867473 @default.
- W2111292073 hasConceptScore W2111292073C2780352672 @default.
- W2111292073 hasConceptScore W2111292073C502942594 @default.
- W2111292073 hasConceptScore W2111292073C54355233 @default.
- W2111292073 hasConceptScore W2111292073C55493867 @default.
- W2111292073 hasConceptScore W2111292073C71924100 @default.
- W2111292073 hasConceptScore W2111292073C73588182 @default.
- W2111292073 hasConceptScore W2111292073C81885089 @default.
- W2111292073 hasConceptScore W2111292073C86803240 @default.
- W2111292073 hasConceptScore W2111292073C8891405 @default.
- W2111292073 hasConceptScore W2111292073C96232424 @default.
- W2111292073 hasConceptScore W2111292073C98274493 @default.
- W2111292073 hasIssue "11" @default.
- W2111292073 hasLocation W21112920731 @default.
- W2111292073 hasLocation W21112920732 @default.
- W2111292073 hasOpenAccess W2111292073 @default.
- W2111292073 hasPrimaryLocation W21112920731 @default.
- W2111292073 hasRelatedWork W1964568636 @default.